Insulin Icodec Weekly: A Basal Insulin Analogue for Type 2 Diabetes.

touchREV Endocrinol

LMC Diabetes & Endocrinology, Concord, Ontario, Canada.

Published: May 2023

Insulin icodec is a once-weekly basal insulin analogue in late-phase clinical development. Similar efficacy and safety of icodec to once-daily basal insulin analogues have been reported in over 4,200 participants with type 2 diabetes from three phase II and five phase III trials. Indeed, glycated haemoglobin reduction was superior for icodec among insulin-naïve participants (ONWARDS 1, 3 and 5) and in those switching from a daily basal insulin in ONWARDS 2, with the latter trial demonstrating improved diabetes treatment satisfaction scores with insulin icodec versus insulin degludec.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10258611PMC
http://dx.doi.org/10.17925/EE.2023.19.1.4DOI Listing

Publication Analysis

Top Keywords

basal insulin
16
insulin icodec
12
insulin
8
insulin analogue
8
type diabetes
8
icodec weekly
4
basal
4
weekly basal
4
analogue type
4
diabetes insulin
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!